Executive Summary
New federal contracts totaling $3.38B signal robust demand for IT services, construction, and biotech R&D, with 19 bullish awards dominated by GSA (6 contracts) and long-duration deals providing revenue visibility through 2028-2049. Public firms like Booz Allen Hamilton ($818M across 2 awards), Lockheed Martin ($79M across 2), Textron ($134M), and SAIC ($59M) capture significant share amid full/open competition wins. Risks center on firm-fixed-price exposure and low initial outlays ($0 on 7 contracts), but unexercised options (~$1.5B+ potential) offer upside.
Tracking the trend? Catch up on the prior New Federal Contractors digest from February 19, 2026.
Investment Signals(5)
- IT Services Surge via GSA Delivery Orders(HIGH)▲
GSA awards 6 contracts worth $484M+ obligated (potential $1.2B+) to Booz Allen, Tatitlek, Planned Systems, Manta, SAIC, Amentum, focusing on computer systems design (NAICS 541512) with multi-year terms to 2027-2033.
- Defense/Construction Revenue Commitments(HIGH)▲
DoD/Army ($616M Clark hospital build to 2028) and USDA ($242M Kiewit disaster recovery to 2026) awards highlight infrastructure spending, firm-fixed-price with full obligation.
- Biothreat Biotech Funding(MEDIUM)▲
HHS/BARDA awards $365M+ to Paratek ($265M to 2029) and Luminary Labs ($100M to 2028) for antibiotic and R&D, with $139M outlayed signaling execution.
- Aviation & Radar Modernization(HIGH)▲
FAA awards $231M+ to Textron ($134M aircraft to 2031) and Saab ($97M radars to 2039 potential), replacing legacy systems with long-term options.
- NASA Space R&D Longevity(MEDIUM)▲
Lockheed Martin secures $75M obligated (potential $376M) for GEOXO to 2049 and lunar studies, underscoring sustained space investment.
Risk Flags(4)
- Execution[HIGH RISK]▼
Firm-fixed-price structures in 10+ contracts (e.g., Clark $616M, Kiewit $242M, Paratek $265M) expose to cost overruns amid inflation/delays.
- Execution[MEDIUM RISK]▼
$0 outlay on 7 contracts totaling $430M+ (e.g., Tatitlek $114M, Manta $73M, SAIC $59M) signals potential funding/execution delays.
- Market[MEDIUM RISK]▼
Heavy subawarding (e.g., Peraton 53 subs $258M, Amentum 70 subs $16M) risks margin dilution and subcontractor delays.
- Competitive[LOW RISK]▼
End-of-period risks for 5 contracts (e.g., Booz Allen GSA to Apr 2024, Navarro DOE to Mar 2025) with no follow-ons indicated.
Opportunities(3)
- ◆
Unexercised options exceed $1.5B across portfolio (e.g., Peraton $142M, SAIC $268M, Lockheed $297M), extendable to 2033-2049.
- ◆
Small business set-asides yield $500M+ wins (Tatitlek, Manta, Navarro, Luminary), positioning for recurring targeted awards.
- ◆
Fully obligated/outlayed contracts like Perimeter ($64M fire retardant), Navarro ($62M remediation) offer immediate cash flow with repeat potential.
Sector Themes(3)
- ◆
6 GSA awards total $484M obligated (potential $1.9B ceiling) in NAICS 541512/541330, emphasizing multi-year IT/engineering for fed missions.
- ◆
NASA/FAA contracts to 2049/2039 (Lockheed, Textron, Saab) signal modernization pipelines beyond near-term budgets.
- ◆
Hurricane Helene repair ($242M Kiewit) amid moratorium exceptions highlights ad-hoc infra spending spikes.
Watch List(4)
- 👁
{"entity"=>"Booz Allen Hamilton Holding Corp", "reason"=>"$818M across VA/GSA IT awards with $71M+$756M obligations, but GSA ends 2024.", "trigger"=>"Follow-on GSA task orders or Q1 outlay ramp"}
- 👁
{"entity"=>"Lockheed Martin Corp", "reason"=>"$79M NASA space R&D (potential $376M to 2049), dual awards signal program momentum.", "trigger"=>"GEOXO option exercises >$74M obligation"}
- 👁
{"entity"=>"SAIC", "reason"=>"$59M GSA PBGC IT (ceiling $327M to 2033), no outlays yet but massive upside.", "trigger"=>"Initial 2025 outlays confirming execution"}
- 👁
{"entity"=>"Construction Sector (Clark, Kiewit)", "reason"=>"$858M firm-fixed builds/recovery, $0 outlays indicate start risks.", "trigger"=>"Cost overrun reports or delays to 2026-2028"}
Get daily alerts with 5 investment signals, 4 risk alerts, 3 opportunities and full AI analysis of all 22 filings
🇺🇸 More from United States
View all →March 25, 2026
US Pre-Market SEC Filings Roundup — March 25, 2026
US Pre-Market SEC Filings Roundup
March 24, 2026
US Merger & Acquisition SEC Filings — March 24, 2026
US Merger & Acquisition SEC Filings
March 24, 2026
US Corporate Board Director Changes SEC Filings — March 24, 2026
US Corporate Board Director Changes SEC Filings
March 24, 2026
US Executive Officer Management Changes SEC — March 24, 2026
US Executive Officer Management Changes SEC